Sera Prognostics IncSera Prognostics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Medical Equipment, Supplies & Distribution

The page includes a Q&A section for Sera Prognostics Inc. The page displays a free E,S&G report for Sera Prognostics Inc. This assessment of Sera Prognostics Inc employs information from across the internet as well as from available filings by Sera Prognostics Inc.

Sera Prognostics Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 1.9; made up of an environmental score of 0.0, social score of 4.0 and governance score of 1.6.

SDG Transparency Score for Sera Prognostics Inc 

1.9

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Sera Prognostics Inc 
0.0

Environmental

4.0

Social

1.6

Governance

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Bioteque Corp
8.0
High
1Amplitude Surgical SA
8.0
High
.........
299Sinocare Inc
2.0
Medium
299Venus Concept Inc
2.0
Medium
.........
309Sera Prognostics Inc
1.9
Low
309Predictive Oncology Inc
1.9
Low
309Ekso Bionics Holdings Inc
1.9
Low
380ZoomMed Inc
0.0
Low
380iRay Technology Co Ltd
0.0
Low
.........

Frequently Asked Questions

Does Sera Prognostics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Sera Prognostics Inc disclose current and historical energy intensity?
Does Sera Prognostics Inc report the average age of the workforce?
Does Sera Prognostics Inc reference operational or capital allocation in relation to climate change?
Does Sera Prognostics Inc disclose its ethnicity pay gap?
Does Sera Prognostics Inc disclose cybersecurity risks?
Does Sera Prognostics Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Sera Prognostics Inc offer flexible work?
Does Sera Prognostics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sera Prognostics Inc disclose the number of employees in R&D functions?
Does Sera Prognostics Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Sera Prognostics Inc conduct supply chain audits?
Does Sera Prognostics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sera Prognostics Inc conduct 360 degree staff reviews?
Does Sera Prognostics Inc disclose the individual responsible for D&I?
Does Sera Prognostics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sera Prognostics Inc disclose current and / or historical scope 2 emissions?
Does Sera Prognostics Inc disclose water use targets?
Does Sera Prognostics Inc have careers partnerships with academic institutions?
Did Sera Prognostics Inc have a product recall in the last two years?
Does Sera Prognostics Inc disclose incidents of discrimination?
Does Sera Prognostics Inc allow for Work Councils/Collective Agreements to be formed?
Has Sera Prognostics Inc issued a profit warning in the past 24 months?
Does Sera Prognostics Inc disclose parental leave metrics?
Does Sera Prognostics Inc disclose climate scenario or pathway analysis?
Does Sera Prognostics Inc disclose current and / or historical scope 1 emissions?
Does Sera Prognostics Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Sera Prognostics Inc disclose the pay ratio of women to men?
Does Sera Prognostics Inc support suppliers with sustainability related research and development?
Does Sera Prognostics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sera Prognostics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sera Prognostics Inc involved in embryonic stem cell research?
Does Sera Prognostics Inc disclose GHG and Air Emissions intensity?
Does Sera Prognostics Inc disclose its waste policy?
Does Sera Prognostics Inc report according to TCFD requirements?
Does Sera Prognostics Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Sera Prognostics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sera Prognostics Inc disclose energy use targets?
Does Sera Prognostics Inc disclose its Renewable Energy targets?
Are emissions metrics verified by STBi?
Does Sera Prognostics Inc have a policy relating to cyber security?

Potential Risks for Sera Prognostics Inc
These potential risks are based on the size, segment and geographies of the company.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Sorry!

Failed to process!